- Service Name
Avalo Therapeutics
- Industry
Biotechnology, biopharmaceuticals, clinical-stage development, immune therapies
- Main Value Proposition
Avalo Therapeutics offers innovative biopharmaceutical solutions aimed at treating complex immune-related conditions, enhancing patient care through advanced therapies.
- Description
Avalo Therapeutics is a clinical-stage biotechnology company focused on developing treatments for immune dysregulation. The company is advancing innovative therapies, including its lead asset AVTX-009, aimed at addressing inflammatory diseases.
- Key Features
Focus on immune dysregulation treatments; Lead asset AVTX-009 targeting inflammatory diseases; Additional product candidates including quisovalimab and AVTX-008; Clinical-stage biotechnology with a commitment to innovation
- Use Cases
Avalo's therapies are most valuable for patients suffering from inflammatory diseases and immune dysregulation, as well as for healthcare providers seeking effective treatment options.
- Competitive advantages
Strong pipeline of innovative therapies; Expertise in immune dysregulation; Clinical-stage development with promising lead candidates
- Strengths
Avalo Therapeutics is characterized by its commitment to innovation, a focused therapeutic area, and a strong leadership team that supports its growth and strategic direction.
- Positioning
Avalo Therapeutics positions itself as a leader in the biotechnology sector, specifically targeting the treatment of immune dysregulation with a compassionate approach.
- Audience
The target users include patients with immune-related conditions, healthcare professionals, and investors interested in biopharmaceutical advancements.
- CTA
View Investor Relations
- Tags
biotechnology
immune dysregulation
clinical-stage
therapeutics
- Tagline
Driven by Compassion
- Tone of Voice
Compassionate, innovative, professional
- Differentiation
Avalo Therapeutics differentiates itself through its specialized focus on immune dysregulation and its pipeline of targeted therapies, which are designed to address unmet medical needs in inflammatory diseases.
- Brand Positioning
The brand identity of Avalo Therapeutics emphasizes innovation, compassion, and a commitment to improving patient outcomes through advanced biopharmaceutical solutions.
- Founded
2011-01-01
- Founders
Isaac Blech